Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1996-1-4
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0959-8049
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
31A
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1565-6
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:7488401-Aged,
pubmed-meshheading:7488401-Humans,
pubmed-meshheading:7488401-Male,
pubmed-meshheading:7488401-Middle Aged,
pubmed-meshheading:7488401-Patient Selection,
pubmed-meshheading:7488401-Prostate-Specific Antigen,
pubmed-meshheading:7488401-Prostatic Neoplasms,
pubmed-meshheading:7488401-Research,
pubmed-meshheading:7488401-Tumor Markers, Biological
|
pubmed:year |
1995
|
pubmed:articleTitle |
Prostate cancer--what should be studied?
|
pubmed:publicationType |
Editorial,
Comment,
Review
|